<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)*
MAXIM PHARMACEUTICALS, INC.
---------------------------
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE
-----------------------------
(Title of Class of Securities)
57772M107
------------
(CUSIP Number)
Rose Glen Capital Management, L.P.
251 St. Asaphs Rd.
3 Bala Plaza - East
Bala Cynwyd, PA 19004
Attn: Gary S. Karinsky
(610) 617-5900
---------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
December 31, 1999
-----------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ / Rule 13d-1(b)
/X/ Rule 13d-1(c)
/ / Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act.
- - --------------------------------------------------------------------------------
<PAGE>
CUSIP NUMBER: 57772M107 PAGE 2 OF 9 PAGES
1) Names of Reporting Persons; S.S. or I.R.S. Identification
RGC International Investors, LDC
- - --------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) /X/
(b) N/A
- - --------------------------------------------------------------------------------
3) SEC Use Only
- - --------------------------------------------------------------------------------
4) Citizenship or Place of Organization Cayman Islands
- - --------------------------------------------------------------------------------
Number of 5) Sole Voting Power
Shares --------------------------------------------------------
Beneficially
Owned by 6) Shared Voting Power 300,000(1)
Each Reporting --------------------------------------------------------
Person With
7) Sole Dispositive Power
--------------------------------------------------------
8) Shared Dispositive Power 300,000(1)
- - --------------------------------------------------------------------------------
9) Aggregate Amount Beneficially 300,000(1)
Owned by Each Reporting Person
- - --------------------------------------------------------------------------------
10) Check if the Aggregate Amount in Row (9)
Excludes Certain Shares (See Instructions) N/A
- - --------------------------------------------------------------------------------
11) Percent of Class Represented by Amount in Row (9) 2.3%
- - --------------------------------------------------------------------------------
12) Type of Reporting Person (See Instructions) OO
- - --------------------------------------------------------------------------------
<PAGE>
CUSIP NUMBER: 57772M107 PAGE 3 OF 9 PAGES
- - --------------------------------------------------------------------------------
1) Names of Reporting Persons; S.S. or I.R.S. Identification
Rose Glen Capital Management, L.P.
- - --------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) /X/
(b) N/A
- - --------------------------------------------------------------------------------
3) SEC Use Only
- - --------------------------------------------------------------------------------
4) Citizenship or Place of Organization Delaware
- - --------------------------------------------------------------------------------
Number of 5) Sole Voting Power
Shares --------------------------------------------------------
Beneficially
Owned by 6) Shared Voting Power 300,000(1)
Each Reporting
Person With --------------------------------------------------------
7) Sole Dispositive Power
--------------------------------------------------------
8) Shared Dispositive Power 300,000(1)
- - --------------------------------------------------------------------------------
9) Aggregate Amount Beneficially 300,000(1)
Owned by Each Reporting Person
- - --------------------------------------------------------------------------------
10) Check if the Aggregate Amount in Row (9)
Excludes Certain Shares (See Instructions) N/A
- - --------------------------------------------------------------------------------
11) Percent of Class Represented by Amount in Row (9) 2.3%
- - --------------------------------------------------------------------------------
12) Type of Reporting Persons (See Instructions) PN
- - --------------------------------------------------------------------------------
<PAGE>
CUSIP NUMBER: 57772M107 PAGE 4 OF 9 PAGES
- - --------------------------------------------------------------------------------
1) Names of Reporting Persons; S.S. or I.R.S. Identification
RGC General Partner Corp.
- - --------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) /X/
(b) N/A
- - --------------------------------------------------------------------------------
3) SEC Use Only
- - --------------------------------------------------------------------------------
4) Citizenship or Place of Organization Delaware
- - --------------------------------------------------------------------------------
Number of 5) Sole Voting Power
Shares --------------------------------------------------------
Beneficially
Owned by 6) Shared Voting Power 300,000(1)
Each Reporting --------------------------------------------------------
Person With 7) Sole Dispositive Power
--------------------------------------------------------
8) Shared Dispositive Power 300,000(1)
- - --------------------------------------------------------------------------------
9) Aggregate Amount Beneficially 300,000(1)
Owned by Each Reporting Person
- - --------------------------------------------------------------------------------
10) Check if the Aggregate Amount in Row (9)
Excludes Certain Shares (See Instructions) N/A
- - --------------------------------------------------------------------------------
11) Percent of Class Represented by Amount in Row (9) 2.3%
- - --------------------------------------------------------------------------------
12) Type of Reporting Persons (See Instructions) CO
- - --------------------------------------------------------------------------------
<PAGE>
CUSIP NUMBER: 57772M107 PAGE 5 OF 9 PAGES
FOOTNOTES TO COVER PAGE OF SCHEDULE 13G
1. This Amendment No. 1 to Schedule 13G is being filed on behalf of the
following persons (the "Filers"):
(1) RGC International Investors, LDC, a Cayman Islands limited duration
company ("RGC");
(2) Rose Glen Capital Management, L.P., a Delaware limited partnership
("Rose Glen"); and
(3) RGC General Partner Corp., a Delaware corporation ("Partner").
Each of Rose Glen and Partner shall be collectively referred to as the "RGC
Affiliates."
RGC is a private investment fund. Rose Glen is the investment manager of
RGC and Partner is the general partner of Rose Glen. The Common Stock to
which this Schedule 13G relates is owned by RGC. The name, residence or
business address, principal occupation or employment and citizenship of
each of the executive officers of the RGC Affiliates are set forth in the
table on Schedule A hereto.
RGC is reporting that it owns, and Rose Glen as investment manager of RGC
and Partner as general partner of Rose Glen is reporting that they
beneficially own, 300,000 shares of Common Stock or approximately 2.3% of
the outstanding shares of the Issuer. The total number of shares of Common
Stock the Filers are reporting as being beneficially owned by them consists
of 300,000 shares of Common Stock currently issuable within 60 days of the
date hereof upon exercise of Common Stock Purchase Warrants (the
"Warrants"). The Warrants are exercisable at an exercise price of $10.50
and expire on July 20, 2004.
Each of RGC and the RGC Affiliates has sole power to vote and to dispose of
the shares indicated.
SCHEDULE 13G
ITEM 1. (a). NAME OF ISSUER: Maxim Pharmaceuticals, Inc. (the "Issuer")
(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
8899 University Center Lane,
Suite 400, San Diego, California 92122
<PAGE>
CUSIP NUMBER: 57772M107 PAGE 6 OF 9 PAGES
ITEM 2. (a). NAME OF PERSON FILING: This Schedule 13G is being filed on
behalf of the following persons (the "Filers"):
(1) RGC International Investors, LDC, a Cayman Islands limited
duration company ("RGC");
(2) Rose Glen Capital Management, L.P., a Delaware limited
partnership ("Rose Glen"); and
(3) RGC General Partner Corp., a Delaware corporation
("Partner").
Each of Rose Glen and Partner shall be collectively referred
to as the "RGC Affiliates."
RGC is a private investment fund. Rose Glen is the investment
manager of RGC and Partner is the general partner of Rose
Glen. The Common Stock to which this Schedule 13G relates is
owned by RGC. The name, residence or business address,
principal occupation or employment and citizenship of each of
the executive officers of the RGC Affiliates are set forth in
the table on Schedule A hereto.
(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
The business address for each of the RGC Affiliates is 251 St.
Asaphs Road, Suite 200, 3 Bala Plaza - East, Bala Cynwyd,
Pennsylvania 19004. The business address for RGC is c/o SEI
Fund Resources International, Ltd., 30 Herbert Street, Dublin,
Ireland 2. The residence or business address of each of the
executive officers of the RGC Affiliates are set forth in the
table on Schedule A hereto.
(c). CITIZENSHIP: RGC is a Cayman Islands limited duration company.
Rose Glen is a Delaware limited partnership. Partner is a
Delaware corporation. The citizenship of each of the executive
officers of the RGC Affiliates are set forth in the table on
Schedule A hereto.
(d). TITLE OF CLASS OF SECURITIES: Common Stock, $0.001 par value
(the "Common Stock").
(e). CUSIP NUMBER: 57772M107
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b)
OR (c), CHECK WHETHER THE PERSON FILING IS A: N/A
If this statement is filed pursuant to Rule 13d-1(c), check this
box. /X/
<PAGE>
CUSIP NUMBER: 57772M107 PAGE 7 OF 9 PAGES
ITEM 4. OWNERSHIP. For information concerning the ownership of Common Stock
of the Issuer by RGC and the RGC Affiliates, see Items 5 through 9
and 11 of the cover pages to this Schedule 13G and the footnotes
thereto.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this Statement is
being filed to report the fact that as of the date hereof the
reporting person has ceased to be the beneficial owner of more than 5
percent of the class of securities, check the following. /X/
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
RGC has granted to Rose Glen, as investment manager, the sole power
to manage RGC's investments.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. N/A
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. N/A
ITEM 9. NOTICE OF DISSOLUTION OF GROUP. N/A
ITEM 10. CERTIFICATIONS.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
<PAGE>
CUSIP NUMBER: 57772M107 PAGE 8 OF 9 PAGES
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
DATED: February 14, 2000.
RGC INTERNATIONAL INVESTORS, LDC
By: Rose Glen Capital Management, L.P.
By: RGC General Partner Corp.
By: /s/ Wayne D. Bloch
--------------------------------------------
Wayne D. Bloch
Managing Director
ROSE GLEN CAPITAL MANAGEMENT, L.P.
By: RGC General Partner Corp.
By: /s/ Wayne D. Bloch
--------------------------------------------
Wayne D. Bloch
Managing Director
RGC GENERAL PARTNER CORP.
By: /s/ Wayne D. Bloch
--------------------------------------------
Wayne D. Bloch
Managing Director
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE
FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. Section 1001)
<PAGE>
CUSIP NUMBER: 57772M107 PAGE 9 OF 9 PAGES
SCHEDULE A
The name, citizenship and principal occupation or employment of each
executive officer of the RGC Affiliates are set forth below. The business
address of the above listed persons is 251 St. Asaphs Road, Suite 200, 3 Bala
Plaza-East, Bala Cynwyd, Pennsylvania 19004.
<TABLE>
<CAPTION>
NAME AND POSITION CITIZENSHIP PRINCIPAL OCCUPATION OR EMPLOYMENT
- - ----------------- ----------- ----------------------------------
<S> <C> <C>
Wayne D. Bloch United States Managing Director - RGC General Partner Corp.*
Gary S. Kaminsky United States Managing Director - RGC General Partner Corp.*
Steven B. Katznelson Canada Managing Director - RGC General Partner Corp.*
</TABLE>
RGC is governed by a board of directors consisting of Messrs. Bloch, Kaminsky
and Katznelson and three additional persons who are affiliates of RGC's
administrator, SEI Fund Resources International, Ltd. RGC's board of directors
has granted to Rose Glen, as investment manager, the sole power to manage RGC's
portfolio of investments.
* Messrs. Bloch, Kaminsky and Katznelson own all of the outstanding capital
stock of Partner, are the sole officers and directors of Partner and are
parties to a shareholders agreement pursuant to which they collectively
control Partner. Through Partner, Messrs. Bloch, Kaminsky and Katznelson
control Rose Glen.
